1. Introduction. High-throughput biological experiments play a key role in deciphering biological mechanisms behind complex diseases. Advanced experimental techniques allow us to obtain high-resolution genomic information with affordable price. Over the years large amount of omics data are accumulated in public databases and depositories: The Cancer Genome Atlas (TCGA) http://cancergenome.nih.gov, Gene Expression Omnibus (GEO) http://www.ncbi.nlm.nih.gov/geo/ and Sequence Read Archive (SRA) http://www.ncbi.nlm.nih.gov/sra/, just to name a few. For a given transcriptomic study from microarray or RNA-seq, many statistical methods have been developed for detecting differentially expressed (DE) genes as candidate biomarkers (Pan, 2002; Soneson and Delorenzi, 2013) . The analysis of single study, however, contains small to moderate sample size (usually N = 20 ∼ 50), producing unstable and inaccurate results (Simon et al., 2003; Simon, 2005; Domany, 2014) . Meta-analysis to combine multiple transcriptomic studies has become a common practice to improve statistical power and reproducibility. Interested readers may refer to Ramasamy et al. (2008) for a practical guideline of microarray meta-analysis, and Tseng, Ghosh and Feingold (2012) ; Begum et al. (2012) for comprehensive reviews of microarray and genome-wide association study (GWAS) meta-analysis.
Among the numerous meta-analysis methods proposed in the literature, combining p-values from multiple studies is a simple and flexible solution to combine studies of different experimental design and avoid complexity from batch effect (e.g. different studies utilize different platforms or experimental protocols). Multiple hypothesis settings have been considered to address different biological questions. According to Song and Tseng (2014) (see also Birnbaum (1954) ; Li and Tseng (2011) ), three major hypothesis settings have been considered in the literature: HS A targets on detecting biomarkers that are differentially expressed in all cohorts (H 0 : θ ∈ {θ k = 0} vs H A : θ ∈ {θ k = 0}, where θ k is the effect size of study k, 1 ≤ k ≤ K); HS B targets on biomarkers differentially expressed in one or more studies (H 0 : θ ∈ {θ k = 0} vs H A : θ ∈ {θ k = 0}); HS r targets on biomarkers differentially expressed in at least r studies (H 0 : θ ∈ {θ k = 0} vs H A :
I{θ k = 0} ≥ r, where I{·} is an indicator function taking value one if the statement is true and zero otherwise and r is usually pre-specified with K/2 ≤ r ≤ K). Biologically HS A is preferred when the purpose is to find concordant genes across all studies. HS r can be considered as a robust form of HS A to seek for concordant genes in majority of studies. On the other hand, HS B is considered when heterogeneity is expected and we are interested in biomarkers statistically significant in at least one study.
In the literature, HS B is a union-intersection test (UIT, Roy (1953) ) and is also called a conjunction or intersection hypothesis (Benjamini and Heller, 2008) . Many statistical tests have been developed for this hypothesis setting, including Fisher's method (Fisher, 1934 ), Stouffer's (Stouffer et al., 1949) method, minimum p-value method (Tippett, 1931) and many others. Fisher's method defines the test statistic by sum of log-transformed p-values: T F = −2 K k=1 log p k , where p k is the p-value from the k th study; Stouffer's method uses T S = − 1 √ K K k=1 Φ −1 (p k ) where Φ −1 (·) is the inverse CDF of standard normal distribution. A larger Fisher (or Stouffer) score indicates stronger differential expression evidence. Under the null assumption and assuming independence across studies, the null distribution of Fisher's statistics follows χ 2 2K and Stouffer's follows N (0, 1). Although Fisher's method has many theoretical advantages (e.g. asymptotic Bahadur optimality under certain restricted Gaussian assumptions; see Littell and Folks (1971) ), it has a critical pitfall when heterogeneity is expected across studies. For example, suppose p 1 = (0.001, 1, 1) represents p-values of three studies of gene 1 and p 2 = (0.1, 0.1, 0.1) represents p-values of gene 2. Both genes produce the same Fisher's test statistics and meta-analysis p-values (T F = 13.8 and p F = 0.032) but the biological interpretations of the two genes are obviously different. p 1 indicates strong statistical significance only in the first study, while p 2 shows marginal statistical significance in all three studies. To characterize study heterogeneity in meta-analysis, Li and Tseng (2011) proposed an adaptively weighted Fisher's method (AW-Fisher) where the Fisher's score is modified as weighted sum and the 0-1 weights can be viewed as latent variable of whether a study contributes DE information to the meta-analysis (details see Section 2). Aside from additional biological interpretation of AW weights, AW-Fisher also enjoys nice theoretical properties. It has been shown to be admissible (Li and Tseng, 2011) and asymptotic Bahadur optimal under certain Gaussian assumptions (Park et al., 2017+) . In addition, Fisher's method is more powerful when all studies are significant and minimum p-value method is more powerful when only one study has small p-value. AW-Fisher theoretically takes advantage of both methods on their favored extreme situations (Li and Tseng, 2011) . Chang et al. (2013) performed a comprehensive comparative study to evaluate 12 popular microarray meta-analysis methods and categorized them into the three complementary hypothesis settings, HS A , HS B and HS r . AW-Fisher was the best performer in the HS B setting when considering a variety of data and heterogeneity assumptions.
Despite practical and theoretical advantages of AW-Fisher, currently there exist three major issues when applying the method. Firstly, p-value calculation of AW-Fisher has no simple closed-form solution. Permutation analysis is slow and generates low numerical precision of p-values to effectively account for multiple comparisons when thousands of genes are tested simultaneously (Sun and Wright, 2010) . Secondly, the weight estimate for AW-Fisher is a hard classification (i.e. decision of 0 or 1) and is lack of a variability estimate of the weight. Finally, when number of studies K is large, the number of biomarker categories by AW-Fisher weights increases exponentially and becomes intractable. In this paper, we develop methodologies to overcome the three bottlenecks of AW-Fisher. In Section 2, we introduce AW-Fisher and its existing issues in more detail. Section 3 describes an importance sampling technique with spline interpolation and a linear weight search scheme to overcome computational burden. In Section 4, we develop a bootstrap scheme to define a variability index of AW-Fisher weight estimate. In Section 5, to overcome the exponential growth of number of biomarker categories, we extend the bootstrap scheme to obtain a co-membership matrix to gauge the pattern similarity of resulting biomarkers. By applying tight clustering algorithm (Tseng and Wong, 2005) , tight clusters of biomarkers with different meta-patterns are generated for insightful biological interpretation and hypothesis generation. Section 6 shows two real applications in mouse metabolism microarray data and HIV transgenic rat RNA-seq data. Section 7 contains final conclusion and discussion.
2. AW-Fisher and its existing issues. Below we describe method and rationale for AW-Fisher (Li and Tseng, 2011) . Define T ( P; w) = −2
K is the AW weight associated with K studies and P = (P 1 , . . . , P K ) ∈ (0, 1) K is the random variable of input p-value vector for K studies. Under the null distribution and conditional on w, the significance level obtained by
is the cumulative distribution function (CDF) of χ 2 -distribution with degrees of freedom d. The test statistic of AW-Fisher given p-value vector P is defined as (2.1)
The optimal weight forŵ is determined byŵ = w( P) = arg min w L(T ( P; w)). Here we denote by s the mapping from p-value vector to the AW-Fisher test statistic and S is the random variable for AW-Fisher test statistic which can be obtained by S = s( P). We further define signed AW-Fisher weights bŷ
where (θ 1 , . . . ,θ K ) is the estimate of effect size of each study and sign(x) = x/|x| if x = 0 and sign(x) = 0 otherwise. Note thatv k can be 0, 1 or -1 for 1 ≤ k ≤ K. AW-Fisher is appealing in applications since the AW weight estimateŵ characterizes which study contributes to the meta-analysis result. In the previous simple example, we haveŵ = (1, 0, 0) for gene 1 and w = (1, 1, 1) for gene 2, which indicates gene 1 ( P = (0.001, 1, 1)) is a firststudy-specific biomarker while gene 2 ( P = (0.1, 0.1, 0.1)) is an all-studyconsistent biomarker. Figure 1A shows heatmap of candidate biomarkers declared as DE by AW-Fisher's method in a mouse metabolism microarray example combining three studies (tissues): brown fat, heart, liver (see Section 6.1). In each study, VLCAD-/-mutant mice (orange bar on top) were compared to VLCAD+/+ wild-type mice (black bar) and DE analysis was performed using Limma (Smyth, 2005) . Meta-analysis p-values were calculated for each gene using AW-Fisher method. Benjamini-Hochberg's procedure (Benjamini and Hochberg, 1995) was used to account for multiple comparisons and false discovery rate was controlled at 5% level. Among detected biomarkers, some genes are up-regulated DE genes across all tissues (e.g. genes in module I,v = (1, 1, 1))); many others are tissue specific (e.g. heart-specific biomarkers in module III,v = (0, 1, 0)). If applying Fisher's method, these different gene modules will not be distinguished, which may hinder biologists for further biological investigation and hypothesis generation. Despite the advantages of AW-Fisher in theory and applications, applying AW-Fisher currently encounter three major issues outlined below. I In the original paper, Li and Tseng (2011) did not derive a closedform solution for calculating null distribution of AW statistic. Instead, permutation method (permuting case/control labels in each study independently) was suggested. This results in high computing demand, especially high p-value numerical precision is needed to account for multiple comparisons. The searching space of all possible weights also becomes high (2 K − 1) when K goes large. This will limit AW-Fisher in general genomic applications. II The AW weight estimate can generate unexpected discontinuity and is thus not stable. For example, the following two genes were taken from the mouse metabolism example in Figure 1 . P-values of the three tissues for probeset 1419484 a at were (0.000391, 0.0962, 0.00211), and p-values for probeset 1425567 a at were (0.000356, 0.1026, 0.00206). Despite their very similar p-value inputs, 1419484 a at ended up with AW weightŵ = (1, 1, 1) with p-value 5.64 × 10 −5 using AW-Fisher and 1425567 a at produced AW weightŵ = (1, 0, 1) with p-value 5.22 × 10 −5 , showing unstable weight estimate of the second study. In other words, the AW weight estimate is a hard classification with no variability estimate and biomarker categorization is thus unstable. III Given K studies, the resulting genes could be categorized into (3 K − 1) groups based on their unique AW weight estimate and effect size direction (if separating up-regulation and down-regulation into 1 and Brown Heart Liver mean Brown Heart Liver I.
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(1,1,1) -1 weight usingv; see Figure 1 ). This becomes intractable for further biological investigation when K is large. For example, combining K = 5 studies produces 3 5 − 1 = 242 categories of biomarkers.
To solve these issues of AW-Fisher's method, we will present methods for fast p-value computing, variability index, biomarker categorization in the following three sections.
3. Fast computing of AW-Fisher. In this section we will give solutions to the two computational problems mentioned in Issue I. We propose a fast algorithm of searching the adaptive weights in Section 3.1 and an interpolation approach to obtain accurate p-values in Section 3.2. In Supplementary Section I, we also derive closed-form solution for the cases K = 2 to benchmark the performance of the proposed method and K = 3 for the purpose of demonstrating difficulties of closed-form solution in general K.
An almost-linear order fast searching algorithm for AW weightŵ.
Recall that the searching space Ω = { w :
K } contains 2 K −1 non-zero vectors of weights and searching the whole space Ω to find the AW-Fisher test statistic s( P) = min w∈Ω L(T ( P; w)) and the adaptive weights w( P) = arg min w∈Ω L(T ( P; w)) becomes computationally expensive when K is large. The amount of computation is even more challenging when the AW-Fisher's method is applied to genomic data, where the same procedure is repeated for thousands of genes or even millions of SNPs. To overcome this difficulty, we propose a fast algorithm to findŵ based on the ordered p-values
j=1 log(P (j) ) (i.e. the Fisher's statistics using the first k 0 smallest p-values). Then it is straightforward to see that the test statistic involving the first k 0 ordered p-values will generate the most significant L(T ( P; w)) in Ω k 0 . This implies in Ω k 0 , only w k 0 has to be considered for further comparison. Therefore, instead of searching the whole space Ω, it is enough to search only K vectors of weights { w 1 , . . . , w K } to find the adaptive weightsŵ. The proposed fast algorithm contains two steps: firstly sorting K p-values (usually with complexity of O(K) log(K)) and then searching K vectors of weights (with complexity of O(K)). Therefore, the fast searching algorithm proposed in this section reduces the computational complexity from O(2 K ) to O(K log(K)), which can significantly reduce computing time when K is large.
3.2. Importance sampling and interpolation by spline smoothing for fast p-value calculation. Denote by p obs the observed p-values from individual studies and s obs = s( p obs ) the observed AW-Fisher statistics. Theoretically, the p-value of AW-Fisher's method P H 0 (S ≤ s obs ) can be calculated analytically for any K ≥ 2. However, the formulae involves the evaluation of a K-fold integral and the integration domain becomes very complicated for K ≥ 3, which makes the derivation of the closed-form solution tedious and fallible. For illustration, closed-form derivation of K = 2 and K = 3 are shown in Supplementary materials. In Li and Tseng (2011) , a permutation test by randomly permuting class labels in each study was proposed. Although this non-parametric approach has its merit of maintaining gene dependency structure, it is computationally demanding and difficult for generating precise small p-value, such as when p-value < 10 −4 , which is a critical requirement for multiple testing correction on thousands of genes. In this paper, we propose to use importance sampling to obtain an accurate numerical approximation of P H 0 (S ≤ s obs ). Importance sampling is a method to accurately estimate expectation of a function with very small value using Monte Carlo sampling method. The idea behind importance sampling is to draw samples from a suitable new distribution function rather than the original one of interest and assign a weight to each sample based on the ratio of two density functions.
To evaluate AW-Fisher p-value P H 0 (S ≤ s obs ) using importance sampling, we propose a beta-distribution density function f * (·) to draw P instead of natural uniform distribution f (·) so that we can "over-sample" those small p-values that result in a large S. It holds that
where f (·) is the density of P under the null and f * (·) is the proposed density function of P for importance sampling. Importance sampling weight
and E * (·) are the expectation with respect to f (·) and f * (·) respectively. Therefore, we can obtain expectation from the original measure using a more efficient new one by applying weights for different samples in Monte-Carlo method. Under the null hypothesis and independence assumption between different studies, P k ∼ UNIF(0, 1) for all 1 ≤ k ≤ K, so the joint distribution of f ( P) = 1. If we instead use Beta(η, 1) distribution as the proposed distribution of each study for importance sampling, then f
To implement importance sampling, suppose we simulate p i = (p i1 , . . . , p iK ), where p ik
Our p-value evaluation procedure has the following steps: 
We choose η(K, c t ) as the root of φ(η) = c t , which can be numerically obtained using "uniroot()" function in R. This choice of η guarantees half of the simulated samples will effectively contribute to the importance sampling calculation for each targeted c t . However, for c t ≥ 0.01, we set η = 1 since the gain of importance sampling diminishes. 3. (Derive corresponding AW-Fisher statistics for targeted p-value c t ) Next, we derive the corresponding AW-Fisher statistic S K,t for a targeted p-value c t given K. Given K and c t , we use η(K, c t ) (abbreviated as η hereafter) from the previous step to draw are ordered from t 1 , . . . , t 10 7 . Define
Note that m i is monotonically decreasing with m 1 = 1 and m 10 7 ≈ 0. There exists i * such that m i * ≤ c t < m i * +1 . The corresponding AWFisher statistic S K,t given K and c t is chosen as S K,t = t(i * ). 4. (Interpolation to calculate p-value of a given S obs ) From
Step 3, the library of c t and S K,t (t = 1, . . . , 198 and K = 2, . . . , 100) is established for interpolation. For any given AW-Fisher statistic S obs and K, we apply function "splinefun" in R with "monoH.FC" option using (log(S K,t ), log(c t )), where t = 1, 2, . . . , 198, to fit a smooth curve and identify the corresponding p-value of S obs . Note that we apply spline on log-scale p-value to avoid numerical overflow.
Remark. In Step 2, given K, we simulate q ik
∼ Unif(0, 1) and take the power of η, instead of simulating from Beta(η, 1). This design guarantees φ(η) is a monotone function with respect to η by eliminating the uncertainty from sampling q ik for each η.
For any future input p-values, we only need to calculate the AW-Fisher statistics and interpolate the statistics to obtain AW-Fisher p-value by the spline curve fitting. The design of our base library {(log(S K,t ), log(c t )); (t = 1, . . . , 198, and K = 2, . . . , 100)} facilitates accurate estimation for AW-Fisher p-value up to precision of 10 −100 and K up to 100. Although the computation is demanding to generate the base library, it only runs once before we generate our AW-Fisher R package and will not affect computing for users. In fact, it took 6373.5 CPU hours using AMD Opteron(tm) Processor (1.4GHz) to accomplish the whole base library with 10 7 samples for all K s and t s.
3.3. Simulation and numerical evaluation. In section 3.2 we introduced fast computing for AW-Fisher p-value via importance sampling and interpolation by spline smoothing. In this section, this interpolation approach will be compared to the original permutation-based approach in Tseng (2011) and Wang et al. (2012) . The comparisons include evaluation of accuracy and computing speed. In terms of computing speed, our approach applies a new linear sorting algorithm for searching weights and an interpolation for p-value calculation. The improvement of linear sorting algorithm is quite obvious: the searching space reduces from an exponential order O(2 K ) to almost linear order O(K log(K)). Below we utilize the closed-form solution for K = 2 in Appendix as the underlying truth to compare the new approach with the existing permutation approach. The linear sorting does not improve computing speed when K = 2 and the improvement will mainly come from the interpolation. Our simulation setting is as follows:
1. Simulate K = 2 studies, G = 10, 000 genes and 2N subjects (N = 20, 50) with N cases and N controls. 2. Firstly, we simulated correlated gene structure and assumed no effect size for any gene or any study. The procedure generally follows Song and Tseng (2014) . Simulate expression levels of genes in module c for sample n in study k as (X g c1 kn , . . . , X g c20 kn ) ∼ MVN(0, Σ cs ), where 1 ≤ n ≤ 2N and 1 ≤ k ≤ K. For any uncorrelated gene g with C g = 0, simulate the expression level for sample n in study k as X gkn ∼ N(0, σ 2 ), where 1 ≤ n ≤ 2N and 1 ≤ k ≤ K.
Simulate effect sizes and their DE directions for differentially expressed (DE) genes.
(a) Assume that the first G 1 genes are DE in at least one of the combined studies, where
and then randomly simulate subset v g ⊆ {1, . . . , K} such that |v g | = v g . Here v g is the set of studies in which gene g is DE.
(b) For any DE gene g(1 ≤ g ≤ G 1 ), simulate gene-level effect size θ g ∼ N 0.5+ (1, 1), where N a+ denotes the truncated Gaussian dis-tribution within interval (a, ∞). Also simulate study-specific random effect size θ gk ∼ N(θ g , 0.2 2 ).
(c) Simulate d g ∼ BIN(1, 0.5), where 1 ≤ g ≤ G 1 . Here d g is the DE direction for gene g for majority of studies.
4. Add the directed effect sizes to the gene expression levels simulated in
Step 2. For control subjects (1 ≤ n ≤ N ), set the expression levels as X gkn = X gkn . For case subjects (N + 1 ≤ n ≤ 2N ), if 1 ≤ g ≤ G 1 and k ∈ v g , we set the expression levels as X gkn = X gkn + (−1) dg θ gk .
Using the closed-form solution as the underlying truth, we evaluated the performance of AW-Fisher p-value from the interpolation approach and the permutation-based approach. To formally evaluate the accuracy, we utilized root mean square error (rMSE):
where α g is the − log 10 (AW-Fisher p-value) for gene g from the permutation approach or the interpolation approach, β g is the − log 10 (AW-Fisher p-value) for gene g from closed-form solution and the rMSE indicates the accuracy of p-value estimates with smaller rMSE for better estimation. The result for N = 20 is shown in Table 1 and the result for N = 50 is in Supplementary Table 1 . Clearly our proposed interpolation approach is superior to permutation-based approach in terms of both accuracy and computing time. Note that the interpolation approach is even faster than closed-form solution because the interpolation is only based on spline curve fitting using data in the library and does not implement Monte Carlo importance sampling method while the closed form method requires evaluation of power and logarithmic functions.
Variability index of adaptive weights.
4.1. Method for Variability index. As discussed in Issue II in the Section 2, the AW weight estimateŵ g = (ŵ g1 , . . . ,ŵ gK ) is discontinuous as a function of the input p-values and thus may not be stable. Denote by U gk = 4 · Var(ŵ gk ) the variability index of AW weight estimate for gene g in study k. The variability index gauges the stability ofŵ gk , where a smaller variability index indicates a stable AW weight estimate. However, U gk is not easy to evaluate sinceŵ gk is binary. Here, we propose a bootstrap procedure to calculate an estimate of U gk . The procedure is as follows: 1. Obtain a bootstrap sample and repeat the following procedure B (b = 1, . . . , B) times.
• Denote by D k ∈ R G×N k the data matrix of study k, where G is total number of genes and N k is total number of samples for study k. c ki is the case-control label, where i ∈ {1, . . . , N k } is the sample index and c ki = 0 or 1, representing sample i belongs to control or case group.
• Create an empty data matrix D 4.2. Simulation result. We followed the simulation setting in Section 3.3 to evaluate different combinations of biological variance (σ = 1, 1.5, 2) and sample sizes (N = 20, 50, 80) for the performance of the variability index in Figure 2 . The result shows that when the dataset has smaller sample size or larger biological variation, the variability index becomes larger. Since the variability index gauges the stability of AW weight estimate, it can be seen that noisy datasets tend to generate large variability index. Back to the two Affymetrix probes shown in Issue II of Section 2, the variability index ofŵ = (1, 1, 1) in 1419484 a at is (0, 0.932, 0) and variability index of w = (1, 0, 1) in 1425567 a at is (0,0.936,0) , showing unstable weight estimate of the second study for both gene probes. 5. Resampling-based ensemble clustering for biomarker categorization.
5.1. Method for biomarker categorization. In order to categorize detected genes into biomarker groups with similar differential meta-pattern (Issue III), we extended the bootstrapping procedure in Section 4.1 to obtain a comembership matrix for all pairs of genes where each element of the comembership matrix represents a similarity of signed AW weightv of two genes. Specifically, denote byv (Tseng and Wong, 2005 ) ("tight.clust" function within R package "tightClust") to the co-membership matrix V to obtain tight modules. Tight clustering is able to produce tight and stable gene modules without forcing all genes into clusters. The resulting gene modules show unique differentially expressed patterns across multiple studies (namely meta-pattern). We perform the biomarker categorization (clustering) procedure only on declared DE genes at certain false discovery rate cutoff. Genes of each resulting module are then sorted by the variability index and visualized by heatmaps. Below we perform simulation to demonstrate performance of the resampling-based ensemble clustering for biomarker categorization.
5.2. Simulation result for biomarker categorization. To evaluate the performance of biomarker categorization, we adopted a simulation procedure similar to Section 4.2 and Huo, Song and Tseng (2017) . We simulated S = 4 studies in total and 50 control subjects and 50 case subjects in each study. Among the G = 10, 000 genes, we set 4% as homogeneously concordant DE genes, differentially expressed with the same direction in all studies (all positive or all negative). We denote "homo+" as the homogeneously concordant DE genes with all positive effect sizes and "homo−" as the homogeneously concordant DE genes with all negative effect sizes. We also set another 4% as study-specific DE genes -differential expressed only in one study. Among them, 1/4 are DE genes only in the first study with positive effect sizes (denoted as "ssp1+"), 1/4 are DE genes only in the first study with negative effect sizes (denoted as "ssp1−"), 1/4 are DE genes only in the second study with positive effect sizes (denoted as "ssp2+"), and the rest 1/4 are DE genes only in the second study with negative effect sizes (denoted as "ssp2−"). The rest of the genes are non-DE (denoted as "nonDE"). The biological variation parameter σ is set to 1 in this simulation.
We first applied the proposed AW-Fisher method to this simulated dataset. We obtained 794 genes based on FDR at 5% under HS B . Co-membership of these genes were calculated with B = 1, 000 and used as input for our gene module detection using tight clustering algorithm. We identified 6 gene modules in these 794 genes. The detected gene modules are tabulated against the true gene modules simulated in Table 2 (Module 0 contains scattered genes not assigned to any of the six modules). The false discovery rate is well controlled at 34/794 = 4.3% while the nominal FDR is 5%. The detected gene modules clearly correspond to the true modules, and most of the nonDE genes were left out as the noises. The meta-pattern, variability index and AW weight estimates of these 6 modules are shown in Supplementary Figure 1 . This simulation study showed that the proposed algorithm can recover the underlying gene meta-pattern. Table 2  Contingency table of 6. Transcriptomic meta-analysis applications. We applied our proposed methods on two real meta-analysis examples. The first example utilized gene expression of multi-tissue microarray studies with metabolism related knockout mice. The second example utilized multi-brain-region RNAseq studies with HIV transgenic rats. The sample sizes are shown in Supplementary Table 2. 6.1. Mouse metabolism example. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency was found to be associated with energy metabolism disorder in children. Two genotypes of the mouse model -wild type (VL-CAD +/+) and VLCAD-deficient (VLCAD -/-) -were studied for three types of tissues (brown fat, liver and heart) with 3 to 4 mice in each genotype group. Total number of probesets from these three transcriptomic microarray studies is 14,495. Supplementary Table 2a shows details of the study design and the data set is available in supplementary materials. Twosided p-values and effect size were calculated using Limma comparing wild type (VLCAD +/+) versus mutant (VLCAD -/-) mice in each tissue. AWFisher meta-analysis p-values were obtained and q-values were calculated by applying Benjamini-Hochberg procedure. By controlling FDR at 5%, we obtained 967 differentially expressed genes. We calculated the variability index and generated gene co-membership matrix using resampling techniques. We further applied tight clustering algorithm on the co-membership matrix to identify gene modules with unique meta-pattern. In this example, we successfully detected 6 gene modules with different meta-patterns in Figure 1 . For example, the first and second biomarker modules (gene cluster I and II) are concordant genes that are up-regulated (or downregulated) in all tissues. The other biomarker modules have study-specific differential patterns. For example, DE genes in gene module III are up-regulated in heart but not in brown fat or liver. To examine the biological functions of these modules, we performed pathway enrichment analysis for genes in each module using Fisher's exact test. The pathway database was downloaded from Molecular Signatures Database (MSigDB) v5.0 (http:// bioinf.wehi.edu.au/software/MSigDB/), where a mouse-version pathway database were created by combining pathways from KEGG, BIOCARTA, REACTOME and GO databases and mapping all the human genes to their orthologs in mouse using Jackson Laboratory Human and Mouse Orthology Report (http://www.informatics.jax.org/orthology.shtml). We summarized the pathway detection result (see supplementary Excel file 1 for detailed pathway information). Among the six gene modules with distinct meta-patterns, module I is enriched in enzyme activities (e.g. GO COFAC-TOR BINDING; p = 3.85 × 10 −4 ); module II is enriched in pathways for amino acid catabolism (e.g. REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM; p = 9.31 × 10 −5 ); module III is enriched in defense related pathways (e.g. DEFENSE RESPONSE; p = 2.11 × 10 −6 ); module IV is enriched in pathways of metabolism of amino acids (e.g. REAC-TOME METABOLISM OF AMINO ACIDS; p = 2.36 × 10 −3 ); module V is enriched in stimulus related pathways (e.g. EXTERNAL STIMULUS; p = 1.33 × 10 −3 ); For module VI, we did not detect any significantly enriched pathways. Interestingly, all of these pathways are known to be related to different aspects of metabolism, which indicates that our method is able to detect homogeneous and heterogeneous gene modules that are biologically meaningful. The biomarker clustering result enhances meta-analysis interpretation and motivates hypothesis for further biological investigation. For example, it is intriguing why the defense related genes in module III are up-regulated only in heart but not in liver and brown fat, and why the stimulus related genes in module V are down-regulated in heart and liver but not in brown fat. 6.2. HIV transgenic rat RNA-seq data. Li et al. (2013) conducted studies to determine gene expression differences between F344 and HIV transgenic rats using RNA-seq (GSE47474 in Gene expression Omnibus database http: //www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47474). The HIV transgenic rat model is designed to study learning, memory, vulnerability to drug addiction and other psychiatric disorders to HIV positive patients. 12 F334 untreated rats and 12 HIV transgenic rats in prefrontal cortex (PFC), hippocampus (HIP), and striatum (STR) regions are sequenced for RNA-seq (see Supplementary Table 2b . Tophat (Trapnell, Pachter and Salzberg, 2009) was applied for alignment (adopted by Li et al. (2013) ) and the alignment II.
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(1,1,1) results were converted to RNA-seq count data with 16,821 genes by bedtools (Quinlan and Hall, 2010) . Genes with less than 100 total counts within any brain region were filtered out and 11,824 genes remained. Potential outliers were removed by checking the sample correlation heatmaps (see Supplementary Figure 2 ). R package "edgeR" (Robinson, McCarthy and Smyth, 2010 ) was adopted to perform differential expression gene detection and two-sided p-values were obtained. AW-Fisher meta-analysis p-values were evaluated and q-values were obtained by applying Benjamini-Hochberg procedure. By controlling FDR at 30%, we obtained 145 differentially expressed genes. We loose the FDR criteria to 30% since it is well known that the transcriptomic signals in brain are generally weak. We calculated the variability index and performed biomarker categorization by using resampling techniques and tight clustering algorithm. The result is shown in Figure 3 . To examine the biological functions of these modules, we also performed pathway enrichment analysis using the same procedure as in Section 6.1 (see supplementary Excel file 2 for detailed information). As the results show, module I is up-regulated in all the three brain regions, and is enriched in pathways related to response to virus. (e.g. GO RESPONSE TO VIRUS; p = 1.59 × 10 −3 ); module II is down-regulated in all the three brain regions, and is enriched in pathways related to rhythmic process (e.g. GO RHYTH-MIC PROCESS; p = 6.23 × 10 −4 ); module III is especially interesting since it is down-regulated in HIP, but up-regulated in PFC and STR. However we did not detect any significant pathways using MSigDB, possibly due to small module size (only 15 genes). Instead we used a broader mouse pathway database from Gene Ontology Consortium (Bares and Ge, 2015) , which contained broader pathway categories; we found that GO FOREBRAIN DE-VELOPMENT and GO TELENCEPHALON DEVELOPMENT pathways are highly associated with module III (p = 2.82 × 10 −3 and p = 2.84 × 10 −4 ). Since the brain regions are affected by virus, we anticipate that genes responding to virus to be up-regulated, as observed in module I. The downregulation of rhythmic process genes in module II indicates that HIV virus may have caused loss of rhythmic pattern in multiple brain regions. Moreover, because different brain regions have different functions, it is not surprising that some brain development related genes (module III) respond differently to HIV in different brain regions.
7. Conclusion and discussion. Emerging omics datasets in public domain has made genome-wide meta-analysis appealing. Adaptively weighted Fisher's method has become useful and popular in the stance that it will characterizes study-specific contributions to the meta-analysis result. In this paper, we proposed fast computing and biomarker clustering methods to improve application of AW-Fisher. The contributions of this paper are threefold: (1) Previous version of AW algorithm relied on permutation analysis to assess p-values, which set a limitation for accuracy and speed. We proposed a fast computing and weight searching algorithm for AW algorithm based on importance sampling, interpolation and a linear searching complexity of AW weight, which makes the AW-Fisher algorithm more applicable for large-scale genomic applications. (2) We developed an AW-Fisher weight variability index. This is essential to determine stability of AW-Fisher weight estimates. (3) We proposed a biomarker categorization algorithm via a resampling procedure, which can efficiently obtain gene modules of different meta-analysis differential expression pattern (namely meta-patterns). These meta-patterns can help establish biological hypothesis to quantify homogeneous and heterogeneous DE signals across studies and guide next-step biological investigation. Finally, the the superior performances of the proposed methods are demonstrated in simulation and two real applications (mouse brain HIV RNA-seq data and mouse metabolism data).
We note that the adaptive weight concept can be extended from Fisher's method to other p-value combination meta-analysis methods, such as Stouffer's method. The linear weight searching, importance sampling and spline smoothing can equally be applied in order to efficiently obtain accurate pvalues (e.g. AW-Stouffer's method). An R package (calling C++) is available https://github.com/Caleb-Huo/AWFisher and all datasets and programming code used to perform all analyses in this paper are available on author's website.
